Wound Infection Technology

Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...

Allvivo is a biomedical company committed to the development of improved antimicrobial technologies to reduce medical device and wound related infections. Allvivo collaborates with licensees and marketing partners to deliver safe and effective ...